pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,832 catalysts · 5,256 phase readout · 2,298 8k filing · 321 pdufa · 255 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: pdufa×type: phase readout×clear all
type
  • phase readout5,256
  • 8k filing2,298
  • pdufa321
  • earnings255
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07321067: Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes

Sponsor: Ahmed Karam Helmy. Phase: . Conditions: Advanced Hepatocellular Carcinoma (HCC)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02868268: Neuroblastoma Precision Trial

Sponsor: New Approaches to Neuroblastoma Therapy Consortium. Phase: . Conditions: Neuroblastoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06766968: Prolonged Compression Following Foam Sclerotherapy

Sponsor: Pirogov Russian National Research Medical University. Phase: NA. Conditions: Chronic Venous Disorder, Varicose Veins Leg

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07562568: SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell, Conditioning Therapy, SHR2554, Azacytidine

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06720740: The RELIEF™ Ureteral Stent Randomized Controlled Trial

Sponsor: University of California, San Diego. Phase: NA. Conditions: Kidney Stone

full page →ctgov ↗
›RECRUITINGphase readoutNCT05919940: Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO )

Sponsor: Technical University of Munich. Phase: NA. Conditions: ICU Acquired Weakness, Muscle Atrophy, Energy Malnutrition Protein, Quality of Life, Morphological and Microscopic Findings, Metabolic Disturbance

full page →ctgov ↗
›RECRUITINGphase readoutNCT07166289: Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression

Sponsor: Laureate Institute for Brain Research, Inc.. Phase: NA. Conditions: Treatment-Resistant Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT07343440: Trial on the Impact of Indirect Calorimetry-Guided Nutritional Support on Patient-Centered Outcomes in Critically Ill Patients - The OPTICal Study

Sponsor: HEIDEGGER CP. Phase: NA. Conditions: Critical Illness, ICU

full page →ctgov ↗
›COMPLETEDphase readoutNCT07024589: First-in-Human Trial of Oral AN2-502998

Sponsor: AN2 Therapeutics, Inc. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05047250: A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Non-Small Cell Lung Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07687550: Alterations in Spiking Following Muscle Fatigue in Volleyball Players

Sponsor: National Yang Ming Chiao Tung University. Phase: . Conditions: Fatigue

full page →ctgov ↗
›COMPLETEDphase readoutNCT05204550: Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children

Sponsor: Murdoch Childrens Research Institute. Phase: PHASE2. Conditions: COVID-19

full page →ctgov ↗
›COMPLETEDphase readoutNCT07517991: Chlorhexidine and Zinc in Non-Surgical Periodontal Therapy

Sponsor: Ataturk University. Phase: NA. Conditions: Periodontitis, Periodontitis Stage I, Periodontitis Stage II

full page →ctgov ↗
›COMPLETEDphase readoutNCT03958591: Impact of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification

Sponsor: Yanbing Li. Phase: PHASE4. Conditions: Diabetes type2

full page →ctgov ↗
›RECRUITINGphase readoutNCT06529718: Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients

Sponsor: UNICANCER. Phase: PHASE2. Conditions: Biliary Tract Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05051618: Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: Multiple Sclerosis, Major Depressive Disorder

full page →ctgov ↗
›TERMINATEDphase readoutNCT06391918: Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Sponsor: GenVivo, Inc.. Phase: PHASE1. Conditions: Solid Tumor, Adult

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07467720: Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial

Sponsor: Baylor Research Institute. Phase: NA. Conditions: Radiation Protection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07378124: LLL vs. SDL for LBBP: A Non-inferiority RCT

Sponsor: Ningbo No.2 Hospital. Phase: NA. Conditions: Bradycardia, Conduction Block, Atrioventricular

full page →ctgov ↗
›RECRUITINGphase readoutNCT07415382: Frailty, Dual-Task Performance, and Activities of Daily Living in Older Adults

Sponsor: KTO Karatay University. Phase: . Conditions: Older Adults (60 - 85 Years Old)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06147024: Utilizing 3D Printed Personalized Aortic Lesion Models in Preoperative Assessment

Sponsor: Fu Jen Catholic University. Phase: NA. Conditions: Aortic Aneurysm

full page →ctgov ↗
›COMPLETEDphase readoutNCT06965959: Effects of Exergaming and Autogenic Relaxation on Psychological Well-Being in Nursing Home Residents

Sponsor: Cumhuriyet University. Phase: NA. Conditions: Psychological Well-being, Nursing Homes Residents, Aging, Exergaming, Mind-Body Therapies, Quality of Life, Health Promotion

full page →ctgov ↗
›RECRUITINGphase readoutNCT06915116: Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Cancer, Period Problem

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02041416: Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers

Sponsor: City of Hope Medical Center. Phase: . Conditions: Cancer, Solid Tumor, Hematologic Malignancy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06282406: Pupil-Indexed Noninvasive Neuromodulation

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Paresis

full page →ctgov ↗
›RECRUITINGphase readoutNCT04356287: Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis

Sponsor: Marie Hudson, MD. Phase: PHASE1. Conditions: Sclerosis, Systemic, Mesenchymal Stem Cells

full page →ctgov ↗
›RECRUITINGphase readoutNCT07640516: The Analgesic Efficacy of Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Ultrasound Guided Peripheral Nerve Blocks as a Solo Anesthetic Technique in High Risk Patients Undergoing Unilateral Above Knee Amputation .

Sponsor: Kasr El Aini Hospital. Phase: NA. Conditions: Analgesia Assessment, Above Knee Amputation, Fentanyl vs Dexmedetomidine

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07095504: A Study of Cardiac Rehabilitation Intervention to Improve Cardiovascular Health and Outcomes

Sponsor: Mayo Clinic. Phase: NA. Conditions: Cardiovascular Health

full page →ctgov ↗
›RECRUITINGphase readoutNCT06627504: Type 1 Diabetes REst for Metabolic Health

Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Type 1 Diabetes (T1D), Sleep Health

full page →ctgov ↗
›COMPLETEDphase readoutNCT04173104: PET and MRI Imaging of Brain Tumors Using [18F]PARPi

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: EARLY_PHASE1. Conditions: Brain Tumor, Brain Cancer

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07663604: Assessment of Pain Experience in Fibromyalgia

Sponsor: Zülal TATAR. Phase: . Conditions: Pain, Fybromyalgia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06962306: Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery

Sponsor: Duke University. Phase: PHASE4. Conditions: Cleft Palate, Pain, Postoperative Care, Perioperative Care, Children

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07336706: The Effect of Escape Room Simulation on Nursing Students' Knowledge and Academic Self-Efficacy Regarding Stoma Care

Sponsor: Ankara Yildirim Beyazıt University. Phase: NA. Conditions: Stoma, ESCAPE ROOM

full page →ctgov ↗
›COMPLETEDphase readoutNCT07426406: Oral Nutritional Supplement in Adults With or at Risk of Malnutrition

Sponsor: Abbott Nutrition. Phase: NA. Conditions: Gastrointestinal Tolerance

full page →ctgov ↗
›RECRUITINGphase readoutNCT06551116: QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

Sponsor: Abramson Cancer Center at Penn Medicine. Phase: . Conditions: HER2-positive Metastatic Breast Cancer

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07478406: Relatıonshıp Between Pelvıc Floor and Venous Insuffıcıency

Sponsor: Istanbul Arel University. Phase: NA. Conditions: Chronic Venous Insufficiency, Pelvic Floor, Exercise

full page →ctgov ↗
›COMPLETEDphase readoutNCT07423806: Evaluation of Modified Le Fort I Osteotomy for Treating Cleft Lip and Palate Patients

Sponsor: Alexandria University. Phase: PHASE4. Conditions: Cleft Lip Palate, Class III Skeletal Malocclusion, Le Fort; I

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07387614: WEB-BASED SUPPORT PROGRAM FOR CAREGIVERS OF VETERANS WITH DEMENTIA DISCHARGED FROM SKILLED NURSING FACILITIES TO HOME

Sponsor: Baylor College of Medicine. Phase: NA. Conditions: Caregivers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07258121: Study of ZGGS34 in Participants With Advanced Solid Tumors

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Phase: PHASE1. Conditions: Solid Tumor

full page →ctgov ↗
›COMPLETEDphase readoutNCT07697521: Clinical Characteristics, Treatment Patterns, and Outcomes of Hospitalized Patients With Refractory Inflammatory Bowel Disease

Sponsor: Shanghai 10th People's Hospital. Phase: . Conditions: Inflamatory Bowel Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06630806: A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

Sponsor: Sanofi. Phase: PHASE1. Conditions: Plasma Cell Myeloma Refractory

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04886804: Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Neoplasm Metastasis, Non-Small Cell Lung Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07574216: VEDA Study (DHEA vs Estradiol)

Sponsor: University of Arizona. Phase: NA. Conditions: Post-menopause, Pre-menopause, Sexual Function, Menopause, Vaginal Dryness, Painful Intercourse

full page →ctgov ↗
›COMPLETEDphase readoutNCT07471906: Compliance to Vaccination in Children With Diabetes and Their Siblings

Sponsor: Aristotle University Of Thessaloniki. Phase: . Conditions: Type 1 Diabetes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07357506: Reducing Skin Side Effects in Patients Receiving Radiation on Tomotherapy

Sponsor: King Faisal Specialist Hospital & Research Center. Phase: NA. Conditions: Head and Neck Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07653204: Contactless Ultrasound Data Acquisition in Emergency Departments to Discriminate the Origin of Dyspnea and Chest Pain

Sponsor: Austral Diagnostics. Phase: . Conditions: Dyspnea, Chest Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT06698406: Transcultural Validation of the French Version of the " Patients' Endorsement of a Biopsychosocial Model of Chronic Pain " Scale

Sponsor: Benno Rehberg-Klug. Phase: . Conditions: Pain, Chronic

full page →ctgov ↗
›COMPLETEDphase readoutNCT04479306: Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8

full page →ctgov ↗
›TERMINATEDphase readoutNCT06092216: Spesolimab in Pyoderma Gangrenosum

Sponsor: Icahn School of Medicine at Mount Sinai. Phase: PHASE2. Conditions: Pyoderma Gangrenosum

full page →ctgov ↗
›COMPLETEDphase readoutNCT07274514: Virtual Reality on Balance of Parkinson's Disease

Sponsor: Instituto de Investigación Sanitaria Aragón. Phase: NA. Conditions: Parkinson Disease (PD), Immersive Virtual Reality, Physical Therapy

full page →ctgov ↗
← prev
page 100 of 117
next →